These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21235470)

  • 21. A study of the compaction process and the properties of tablets made of a new co-processed starch excipient.
    Mužíková J; Eimerová I
    Drug Dev Ind Pharm; 2011 May; 37(5):576-82. PubMed ID: 21469946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative binder efficiency modeling of dry granulation binders using roller compaction.
    Gupte A; DeHart M; Stagner WC; Haware RV
    Drug Dev Ind Pharm; 2017 Apr; 43(4):574-583. PubMed ID: 27977316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vapor Phase Alkyne Coating of Pharmaceutical Excipients: Discrimination Enhancement of Raman Chemical Imaging for Tablets.
    Yamashita M; Sasaki H; Moriyama K
    J Pharm Sci; 2015 Dec; 104(12):4093-4098. PubMed ID: 26343262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compression physics in the formulation development of tablets.
    Patel S; Kaushal AM; Bansal AK
    Crit Rev Ther Drug Carrier Syst; 2006; 23(1):1-65. PubMed ID: 16749898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: physicochemical and technological characterisation.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2009 May; 72(1):138-47. PubMed ID: 19146956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model.
    Viscasillas Clerch A; Fernandez Campos F; Del Pozo A; Calpena Campmany AC
    Drug Dev Ind Pharm; 2013 Jul; 39(7):961-9. PubMed ID: 22607083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Micromeritic evaluation of the direct compression excipient LubriTose AN].
    Zhang YL; Tian C; Hu DR; Ke X; Tian JL
    Yao Xue Xue Bao; 2012 May; 47(5):640-5. PubMed ID: 22812010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms.
    Veronica N; Heng PWS; Liew CV
    Mol Pharm; 2024 May; 21(5):2484-2500. PubMed ID: 38647432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
    Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
    AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of stevia on the flow, shear and compression behavior of sorbitol, a pharmaceutical excipient for direct compression.
    Hurychová H; Ondrejček P; Šklubalová Z; Vraníková B; Svěrák T
    Pharm Dev Technol; 2018 Feb; 23(2):125-131. PubMed ID: 28375037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving powder flow properties of a direct compression formulation using a two-step glidant mixing process.
    Abe H; Yasui S; Kuwata A; Takeuchi H
    Chem Pharm Bull (Tokyo); 2009 Jul; 57(7):647-52. PubMed ID: 19571406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of cocoa butter as potential lubricant for coprocessing in pharmaceutical tablets.
    Adeagbo AA; Alebiowu G
    Pharm Dev Technol; 2008; 13(3):197-204. PubMed ID: 18484488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical analysis in the evaluation of reconstituted dry emulsion tablets.
    Niczinger NA; Kállai-Szabó B; Lengyel M; Gordon P; Klebovich I; Antal I
    J Pharm Biomed Anal; 2017 Feb; 134():86-93. PubMed ID: 27889669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
    Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
    Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact Of Excipient Variability On Drug Product Processing And Performance.
    Peng Soh JL; Liew CV; Sia Heng PW
    Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.